US Broker Ratings

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Analyst Consensus and 12% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH), a key player in the healthcare sector, has drawn attention from investors with its strong portfolio of over-the-counter (OTC) health and personal care products...

Repligen Corporation (RGEN) Investor Outlook: Exploring a 44.7% Potential Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector focusing on medical instruments and supplies, presents a captivating investment opportunity with a notable potential upside of 44.7%. With..

BioNTech SE (BNTX) Investor Outlook: Analyzing a 25.91% Potential Upside Amid Robust Pipeline

BioNTech SE (NASDAQ: BNTX) stands as a beacon in the biotechnology industry, particularly known for its contributions to immunotherapy for cancer and infectious diseases. The German-based company, with a market..

Masimo Corporation (MASI) Stock Analysis: Navigating Growth in the Medical Devices Sector

Masimo Corporation (NASDAQ: MASI) stands at the forefront of the healthcare industry with its innovative medical devices and patient monitoring technologies. Based in Irvine, California, Masimo has carved out a..

Corcept Therapeutics (CORT) Stock Analysis: Exploring an 83% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) has recently caught the attention of investors, with an impressive potential upside of 83.19% as indicated by analyst target prices. This biopharmaceutical company, based in..

Integer Holdings Corporation (ITGR) Stock Report: Evaluating Growth Potential in the Medical Devices Sector

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, particularly within the medical devices industry, presents a compelling investment opportunity for those eyeing growth in the ever-evolving..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unpacking a 50.49% Potential Upside in the Biotech Sector

For investors with a keen eye on the biotechnology sector, BridgeBio Pharma, Inc. (NASDAQ: BBIO) presents an intriguing opportunity. With a market capitalization of $12.89 billion, this Palo Alto-based biopharmaceutical..

Natera, Inc. (NTRA) Stock Analysis: A 25% Upside Potential with Strong Buy Ratings

Natera, Inc. (NASDAQ: NTRA), a pioneering player in the diagnostics and research sector, presents an intriguing opportunity for investors seeking growth in the healthcare industry. With a market capitalization of..

ADMA Biologics Inc (ADMA) Stock Analysis: Riding the Wave of a 64.85% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA) is a noteworthy player in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $3.72 billion, this American biopharmaceutical company is..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 7.41% Upside in the Healthcare Sector

As an investor in the healthcare sector, keeping an eye on Alcon Inc. (ALC) could be a prudent move. With a market capitalization of $43.58 billion, Alcon has firmly established..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Biotech Powerhouse with 15.60% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leading player in the biotechnology sector, is capturing investor attention with its promising portfolio of RNA-targeted therapies and a potential upside of 15.60%. The..

Waters Corporation (WAT) Investor Outlook: Evaluating a Potential 24.63% Upside

Waters Corporation (NYSE: WAT), a leader in the healthcare sector’s diagnostics and research industry, is making waves with its analytical workflow solutions across Asia, the Americas, and Europe. With a..

Waystar Holding Corp. (WAY) Stock Analysis: Capitalize on a 44.25% Potential Upside in Healthcare Tech

Waystar Holding Corp. (NASDAQ: WAY) is steadily positioning itself as a significant player in the healthcare technology arena, offering a compelling investment opportunity for those keen on the intersection of..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 32% Potential Upside in the Healthcare Sector

IQVIA Holdings, Inc. (IQV) is proving to be a compelling investment opportunity within the healthcare sector, boasting a significant potential upside of 32.12% according to the latest analyst ratings. Positioned..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Innovator with a 21% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH), a stalwart in the healthcare sector, is capturing investor attention with its robust portfolio of diagnostic and therapeutic products. With a market capitalization of $5.09..

ResMed Inc. (RMD) Stock Analysis: Exploring a 16% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a leading player in the healthcare sector specializing in medical instruments and supplies, offers investors an intriguing opportunity with a potential upside of 16.08%. With a..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Challenges with a Diverse Vaccine Pipeline

Moderna, Inc. (NASDAQ: MRNA), a leader in the biotechnology sector, has generated considerable attention for its groundbreaking work in messenger RNA (mRNA) medicines. Headquartered in Cambridge, Massachusetts, Moderna has gained..

Bio-Techne Corp (TECH) Stock Analysis: Potential 27.54% Upside Amidst Market Challenges

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the healthcare sector, specializes in biotechnology with a focus on life science reagents, instruments, and services. The Minneapolis-based company, with a market..

Chemed Corp (CHE) Stock Analysis: Navigating A Stable Healthcare Giant with 8% Upside Potential

Individual investors eyeing opportunities in the healthcare sector should consider Chemed Corp (CHE), a stalwart in the medical care facilities industry. With a substantial market capitalization of $5.97 billion, Chemed..

Guardant Health, Inc. (GH) Stock Analysis: A 41% Upside Potential with Strong Buy Ratings

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, is capturing the attention of investors with its innovative approach in the diagnostics and research sector. The company’s cutting-edge blood..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds